Neurotech International Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
In the deck
Earlier from Neurotech International
- Appointment of Peter Griffiths as CEO
- New Appointments
- Quarterly report
- Shipment of Mente Autism devices
- Mente Autism - FDA Clearance Application
Later from Neurotech International
- Prospectus - Renounceable Rights Issue
- Supplementary Prospectus
- Renounceable pro-rata rights issue
- Appendix 4D and 31 December 2018 Half Year Report
- Dr Adrian Attard Trevisan
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International